Trials / Unknown
UnknownNCT04326166
Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.
Multi-center, Open, Non-intervention and Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab. in Patients With Type 2 Diabetes
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,971 (estimated)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
Multi-center, open, non-intervention and observational study to Evaluate the efficacy and safety of Suganon tab. or Sugamet XR tab. in patients with Type 2 diabetes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Evogliptin | Evogliptin |
| DRUG | Evogliptin | Evogliptin |
| DRUG | Metformin and Evogliptin | Metformin and Evogliptin |
Timeline
- Start date
- 2020-03-25
- Primary completion
- 2021-07-31
- Completion
- 2021-07-31
- First posted
- 2020-03-30
- Last updated
- 2021-02-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04326166. Inclusion in this directory is not an endorsement.